US Broker Ratings

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 30.9% Revenue Growth in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH), a pioneering leader in the precision oncology sector, is capturing the attention of investors with its robust 30.9% revenue growth, despite recent challenges reflected in..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 42.65% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a leading player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing proposition for investors keen on the life sciences domain. With..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention

In the dynamic world of biotechnology, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out as a notable player with potential for substantial growth. Headquartered in Dublin, Ireland, this healthcare sector company..

Verona Pharma plc (VRNA) Stock Analysis: Evaluating Growth Potential Amidst a $9.07 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical company, has been garnering attention in the healthcare sector, particularly within the biotechnology industry. Specializing in the development and commercialization of therapies..

Globus Medical, Inc. (GMED) Stock Analysis: Discovering a 44% Potential Upside

For investors keen on healthcare opportunities, Globus Medical, Inc. (NYSE: GMED) presents an intriguing prospect within the medical devices sector. Headquartered in Audubon, Pennsylvania, the company has cemented its position..

Option Care Health, Inc. (OPCH) Stock Analysis: Poised for a 42% Upside with Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector specializing in home and alternate site infusion services, is drawing significant attention from investors due to its..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Compelling 78% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity with a strong potential upside. With a market capitalization of $10.34..

Glaukos Corporation (GKOS) Stock Analysis: Navigating the 52.65% Potential Upside in the Healthcare Sector

Glaukos Corporation (GKOS), a key player in the healthcare sector, stands out in the niche field of ophthalmic pharmaceuticals and medical technology. With a focus on developing innovative therapies for..

Chemed Corp (CHE) Stock Analysis: Unpacking the 25% Potential Upside in Healthcare

For investors seeking an intriguing opportunity in the healthcare sector, Chemed Corp (NYSE: CHE) presents a compelling case. With a market capitalization of $6.74 billion, Chemed operates primarily in the..

Legend Biotech (LEGN) Stock Analysis: Unlocking a 129.77% Potential Upside in the Biotech Arena

Legend Biotech Corporation (NASDAQ: LEGN), a trailblazer in the biopharmaceutical realm, is capturing investor attention with a significant 129.77% potential upside. As a leader in developing innovative cell therapies, Legend..

Centene Corporation (CNC) Stock Analysis: Understanding the Healthcare Giant’s Current Valuation and Investor Sentiment

Centene Corporation (NYSE: CNC), a formidable player in the healthcare plans industry, is currently in the spotlight for investors seeking to navigate the complexities of the healthcare sector. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a Potential 212.93% Upside

For investors with an eye for opportunities in the biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents an intriguing prospect. Despite the company’s current share price of $33.98, analysts have set..

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 20% Upside Amid High Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, has caught the attention of investors with its enticing potential upside of 20.05%, according to analysts’ projections. Trading at..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 31.96% Potential Upside Amid Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG), a prominent leader in the healthcare sector’s Medical Instruments & Supplies industry, is drawing significant attention from investors. With a robust market capitalization of $158.13..

Alkermes plc (ALKS) Stock Analysis: Exploring a 49.54% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical company, stands out in the healthcare sector with a promising potential upside of 49.54%, capturing the attention of investors looking for growth opportunities..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Remarkable 71.84% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is a biotechnology firm that is attracting significant attention within the healthcare sector. Headquartered in Redwood City, California, this clinical-stage precision oncology company is pioneering..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with Strong Buy Ratings and Strategic Collaborations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, has been making waves with its innovative therapeutic solutions based on ribonucleic acid interference (RNAi). With a market capitalization..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring Growth Potential Amid 1,353.80% Revenue Surge

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is attracting significant attention from investors, thanks to its remarkable revenue growth of 1,353.80%. This Pennsylvania-based company is..

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 6.87% Potential Upside with Robust Growth and Dividend Stability

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector and a leading player in the medical devices industry, commands a significant presence with a market capitalization of $232.44 billion...

Natera, Inc. (NTRA) Stock Analysis: Evaluating the 18.92% Upside Potential in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare diagnostics sector, offers a suite of advanced molecular testing services that are gaining significant traction worldwide. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds